Zimmer Biomet Holdings (ZBH) Short term Debt (2011 - 2026)

Zimmer Biomet Holdings' Short term Debt history runs 16 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Short term Debt rose 95.98% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 95.98% increase from a year earlier, with the FY2025 full-year figure at $587.1 million, down 31.97% from the prior year.
• Short term Debt advanced to $1.2 billion in Q1 2026 per ZBH's latest filing, from $587.1 million in the prior quarter.
• Across five years, Short term Debt topped out at $1.9 billion in Q2 2024 and bottomed at $355.0 million in Q3 2023.
• The 5-year median for Short term Debt is $820.0 million (2025), against an average of $861.0 million.
• Across the five-year window, Short term Debt tumbled 66.09% in 2022 and soared 382.54% in 2024, its largest moves.
• Year by year, Short term Debt stood at $544.3 million in 2022, then surged by 65.35% to $900.0 million in 2023, then slipped by 4.11% to $863.0 million in 2024, then tumbled by 31.97% to $587.1 million in 2025, then jumped by 100.29% to $1.2 billion in 2026.
• Per Business Quant, the three latest ZBH Short term Debt figures stand at $1.2 billion (Q1 2026), $587.1 million (Q4 2025), and $600.0 million (Q3 2025).